We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen's pipeline includes six product candidates, including five ... Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen's pipeline includes six product candidates, including five clinical-stage investigational agents belonging to a new class of drugs known as pherines. Its portfolio includes PH94B, a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia. PH10, an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression. Show more
PH15 nasal spray demonstrates statistically significant efficacy versus placebo and caffeine in a placebo-controlled Phase 2A pilot study in sleep-deprived participants PH15 was safe and...
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological...
Key study underway in registration-directed PALISADE Phase 3 program for fasedienol in social anxiety disorder Social anxiety disorder affects over 25 million Americans Vistagen (Nasdaq: VTGN), a...
Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today...
Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0533 | 1.13888888889 | 4.68 | 5 | 4.55 | 160685 | 4.75955229 | CS |
4 | -0.6667 | -12.3462962963 | 5.4 | 5.74 | 4.53 | 243260 | 5.09035186 | CS |
12 | -0.0367 | -0.769392033543 | 4.77 | 5.74 | 3.9114 | 261053 | 4.86216407 | CS |
26 | 1.6433 | 53.1812297735 | 3.09 | 5.86 | 2.4501 | 404306 | 4.4453807 | CS |
52 | 0.5963 | 14.4138264443 | 4.137 | 24.71 | 1.62 | 1213331 | 6.12073421 | CS |
156 | -58.2667 | -92.4868253968 | 63 | 106.5 | 1.62 | 3378912 | 16.71360682 | CS |
260 | -26.7667 | -84.9736507937 | 31.5 | 106.5 | 1.62 | 2544602 | 21.78905118 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions